The hope was that if people weren't out drinking, they wouldn't be spreading the coronavirus. There were unforeseen benefits to the ban, which ended last month — and negative impacts as well.
For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.
A study raised concerns about its effectiveness against the coronavirus variant sweeping through the country — although the data is too preliminary for definitive conclusions.
African TV execs say it's unlike any show for kids that's been produced and broadcast on the continent — especially with its focus on women presenters and scientists.
In a new round of tests, the drug company wants to see if booster doses of its vaccine will ramp up defenses against emerging strains of the coronavirus.